首页> 外文期刊>Nitric oxide: Biology and chemistry >P65. Acyloxy nitroso compounds as hno donors, without the release of nitrite, and their reactions with thiol and heme proteins
【24h】

P65. Acyloxy nitroso compounds as hno donors, without the release of nitrite, and their reactions with thiol and heme proteins

机译:P65。酰氧基亚硝基化合物作为hno供体,不释放亚硝酸盐及其与硫醇和血红素蛋白的反应

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Nitroxyl (HNO/NO~-) is the reduced relative of nitric oxide (NO), a biologically relevant signaling agent. Nitroxyl has distinct biological properties when compared to NO and is a potential treatment of myocardial reperfusion injury and congestive heart failure. Nitroxyl must be generated from donors, and a limited number of these compounds exist. Angeli’s salt (AS) is the most widely used HNO donor, but at physiological pH, nitrite is also formed during decomposition of AS. The synthesis of new HNO donors is an objective of this research, specifically acyloxy nitroso compounds. Acyloxy nitroso compounds act as HNO donors through ester hydrolysis to give an unstable intermediate that decomposes to HNO, without generation of nitrite. Varying the R group of the ester portion of these structures varies the stability and reactivity of these compounds, while addition of esterase to water-soluble acyloxy nitroso compounds increases the rate of hydrolysis. These compounds react with thiols and inhibit the thiol containing enzyme aldehyde dehydrogenase (ALDH). Acyloxy nitroso compounds also react with the heme protein myoglobin (Mb). Better understanding of the reaction of HNO with thiol and heme proteins will further the use of HNO donors as therapies.
机译:硝基氧基(HNO / NO〜-)是一氧化氮(NO)的还原体,一氧化氮是一种生物学相关的信号传导剂。与NO相比,硝基氧具有独特的生物学特性,是治疗心肌再灌注损伤和充血性心力衰竭的潜在方法。硝基氧基必须由供体产生,并且存在有限数量的这些化合物。安吉利盐(AS)是使用最广泛的HNO供体,但在生理pH值下,AS分解时也会形成亚硝酸盐。合成新的HNO供体是这项研究的目标,特别是酰氧基亚硝基化合物。酰氧基亚硝基化合物通过酯水解充当HNO供体,生成不稳定的中间体,该中间体分解为HNO,而不会产生亚硝酸盐。通过改变这些结构的酯部分的R基团,可以改变这些化合物的稳定性和反应性,同时在水溶性酰氧基亚硝基化合物中添加酯酶可以提高水解速率。这些化合物与硫醇反应并抑制含硫醇的酶醛脱氢酶(ALDH)。酰氧基亚硝基化合物还与血红素蛋白肌红蛋白(Mb)反应。更好地了解HNO与硫醇和血红素蛋白的反应将进一步使用HNO供体作为治疗方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号